LysoPC(18:2)
|
Basic information |
| Metabolite name | LysoPC(18:2) |
 | N/A |
 |
C04230 |
 |
N/A |
| Synonyms | LPC(18:2); |
| No. of studies | 15 |
|
Basic information |
| Metabolite name | LysoPC(18:2) |
| N/A |
|
C04230 |
|
N/A |
| Synonyms | LPC(18:2); |
| No. of studies | 15 |
|
Relationship between LysoPC(18:2) and depression (count: 15) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M039 | Type1 | CRS group vs. control group | Plasma | Wistar rat | Up |
| Study M1024 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | Serum | ICR mouse | Up |
| Study M1105 | Type1 | psychological stress group vs. control group | Faece | C57BL/6 J mouse | Down |
| Study M122 | Type3 | paroxetine group vs. control group | Prefrontal cortex | BALB/c mouse | Up |
| Study M122 | Type3 | maprotiline group vs. control group | Prefrontal cortex | BALB/c mouse | Up |
| Study M123 | Type3 | rTMS group vs. control group | Striatum | Wistar rat | Down |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Up |
| Study M582 | Type1 | CUMS group vs. control group | Serum | C57BL/6N mouse | Up |
| Study M582 | Type3 | control + fluoxetine group vs. control group | Serum | C57BL/6N mouse | Down |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Serum | C57BL/6 J mouse | Up |
| Study M695 | Type2 | CUMS + Schisandra chinensis group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
| Study M743 | Type1 | CUS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M789 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M789 | Type2 | CUMS + liquiritin group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M789 | Type2 | CUMS + fluoxetine group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M880 | Type1 | depression group vs. control group | Plasma | Cynomolgus monkey | Down |
| Study M890 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M907 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M948 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |